CA2244862A1 - Substituted amide derivatives - Google Patents

Substituted amide derivatives

Info

Publication number
CA2244862A1
CA2244862A1 CA002244862A CA2244862A CA2244862A1 CA 2244862 A1 CA2244862 A1 CA 2244862A1 CA 002244862 A CA002244862 A CA 002244862A CA 2244862 A CA2244862 A CA 2244862A CA 2244862 A1 CA2244862 A1 CA 2244862A1
Authority
CA
Canada
Prior art keywords
group
represented
lower alkyl
atom
oxygen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002244862A
Other languages
French (fr)
Other versions
CA2244862C (en
Inventor
Yoshikazu Iwasawa
Tetsuya Aoyama
Kumiko Kawakami
Sachie Arai
Toshihiko Satoh
Yoshiaki Monden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Pharmaceutical Co., Ltd.
Yoshikazu Iwasawa
Tetsuya Aoyama
Kumiko Kawakami
Sachie Arai
Toshihiko Satoh
Yoshiaki Monden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharmaceutical Co., Ltd., Yoshikazu Iwasawa, Tetsuya Aoyama, Kumiko Kawakami, Sachie Arai, Toshihiko Satoh, Yoshiaki Monden filed Critical Banyu Pharmaceutical Co., Ltd.
Priority claimed from PCT/JP1997/000304 external-priority patent/WO1997029073A1/en
Publication of CA2244862A1 publication Critical patent/CA2244862A1/en
Application granted granted Critical
Publication of CA2244862C publication Critical patent/CA2244862C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to a compound represented by general formula (I) or a pharmaceutically acceptable salt or ester thereof:
(see formula I) (wherein each of (see formula II) is an aryl group or an aromatic heterocyclic group; A1 is a C1-6 chain hydrocarbon group or a group represented by -A1a-W1-A1b- (wherein W1 is an oxygen atom, a sulfur atom, an ethynylene group, a cyclopropylene group or a group represented by -NR w-); A2 is a C1-8 chain hydrocarbon group; R1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a group represented by R a COO-(wherein R a is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or by R b CONR c- (wherein R b is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or an alicyclic group; R2 is a lower alkyl group; and each of X and Y is an oxygen atom, a sulfur atom, a carbonyl group, a group represented by -CHR d- or by -NR e-, or X and Y together represent a vinylene group or an ethynylene group, provided that when one of X and Y is an oxygen atom, a sulfur atom or group represented by -NR e-, the other is a carbonyl group or a group represented by -CHR d-] and an antitumor agent comprising it as an active ingredient.
CA002244862A 1996-02-07 1997-02-07 Substituted amide derivatives Expired - Fee Related CA2244862C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4550296 1996-02-07
JP8/45502 1996-02-07
PCT/JP1997/000304 WO1997029073A1 (en) 1996-02-07 1997-02-07 Substituted amide derivatives

Publications (2)

Publication Number Publication Date
CA2244862A1 true CA2244862A1 (en) 1997-08-14
CA2244862C CA2244862C (en) 2006-03-28

Family

ID=36123391

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002244862A Expired - Fee Related CA2244862C (en) 1996-02-07 1997-02-07 Substituted amide derivatives

Country Status (1)

Country Link
CA (1) CA2244862C (en)

Also Published As

Publication number Publication date
CA2244862C (en) 2006-03-28

Similar Documents

Publication Publication Date Title
AU3192395A (en) Substituted amide derivative
EP0805154A4 (en)
CA2277947A1 (en) Pyrrolidine derivatives having phospholipase a2 inhibitory activity
DK0819125T3 (en) Thienyl, furyl, pyrrolyl and biphenylsulfonamides and derivatives thereof which modulate the activity of endothelin
WO2003043992A1 (en) 4-oxoquinoline derivatives
EP1026149A4 (en) Amidocarboxylic acid derivatives
CA2102591A1 (en) Hypoglycemic Agent
CA2088798A1 (en) Condensed imidazopyridine derivatives
EP0882714A4 (en) Substituted vinylpyridine derivatives and drugs containing the same
CA2129542A1 (en) Pharmaceutical preparation based on rhamnolipid
EP0786252A4 (en) Antitumor agent
CA2244862A1 (en) Substituted amide derivatives
CA2487033A1 (en) Amide substituted xanthine derivatives with gluconeogenesis modulating activity
AU1619297A (en) Substituted amide derivatives
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
AU1890299A (en) Potassium channel activators
EP1142868A4 (en) Amide derivatives
WO1997029077A1 (en) Substituted amide derivatives
CA2244695A1 (en) Cyclic amic acid derivatives
WO1997029074A1 (en) N,n-disubstituted amic acid derivatives
EP0685461A4 (en) 5-aminoacetylaminosulfonanilide compound.
CA2236851A1 (en) Substituted vinylpyridine derivatives and drugs containing the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed